| Application no. and date | 18851555.5 (espacenet) (Federated) (European Patent Register), 20180831 | | Patent/reg. no. and date | DK/EP 3677266, 20240117 | | Publication date | 20200708 | | Priority no. and date | JP 2017168606, 20170901 | | EP pub. no. and date |
EP 3677266 20200708 | | Effective date | | | Applicant/owner | Taiho Pharmaceutical Co., Ltd., 1-27, Kandanishiki-cho
Chiyoda-ku, Tokyo 101-8444, JP | | Applicant ref. no. | PU279409DKQ | | Inventor | HASAKO, Shinichi, c/o TAIHO PHARMACEUTICAL Co. Ltd.
3 Okubo
Tsukuba-shi
Ibaraki 300-2611, JP,
ABE, Naomi, c/o TAIHO PHARMACEUTICAL CO. LTD.
3 Okubo
Tsukuba-shi
Ibaraki 300-2611, JP | | Representative | Marks & Clerk LLP, 44, rue de la Vallée
L-2661 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61P 35/00 (2006.01) , C12N 9/99 (2006.01) | | Title | EXON-18- OG/ELLER EXON-21-MUTANT EGFR-SELEKTIV HÆMMER | | Int. application no. | JP2018032314 | | Int. publication no. | WO2019045036 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
